Alembic Pharmaceuticals Annual Report 2021

Alembic Pharmaceuticals Limited's 2020-21 annual report detailing the company's diversified pharmaceutical portfolio across international generics, domestic branded medicines, and APIs. The report highlights strong financial performance with revenues of ₹5,393 crores and discusses strategic initiatives in specialty therapeutics including oncology, dermatology, and ophthalmic products.